These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 36597584)

  • 1. The complement system in preeclampsia: a review of its activation and endothelial injury in the triad of COVID-19 infection and HIV-associated preeclampsia.
    David M; Naicker T
    Obstet Gynecol Sci; 2023 Jul; 66(4):253-269. PubMed ID: 36597584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular Endothelial Growth Factor Receptor 2: Molecular Mechanism and Therapeutic Potential in Preeclampsia Comorbidity with Human Immunodeficiency Virus and Severe Acute Respiratory Syndrome Coronavirus 2 Infections.
    Abel T; Moodley J; Khaliq OP; Naicker T
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis.
    Gralinski LE; Sheahan TP; Morrison TE; Menachery VD; Jensen K; Leist SR; Whitmore A; Heise MT; Baric RS
    mBio; 2018 Oct; 9(5):. PubMed ID: 30301856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal endothelial dysfunction in HIV-associated preeclampsia comorbid with COVID-19: a review.
    Naidoo N; Moodley J; Naicker T
    Hypertens Res; 2021 Apr; 44(4):386-398. PubMed ID: 33469197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropilin-1 in the pathogenesis of preeclampsia, HIV-1, and SARS-CoV-2 infection: A review.
    Naidoo N; Moodley J; Khaliq OP; Naicker T
    Virus Res; 2022 Oct; 319():198880. PubMed ID: 35905790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
    J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Involvement of MicroRNAs in SARS-CoV-2 Infection Comorbid with HIV-Associated Preeclampsia.
    Abel T; Moodley J; Naicker T
    Curr Hypertens Rep; 2021 Apr; 23(4):20. PubMed ID: 33847825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
    Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Pathogenesis, Immunopathogenesis and Novel Therapeutic Strategy Against COVID-19.
    Chatterjee SK; Saha S; Munoz MNM
    Front Mol Biosci; 2020; 7():196. PubMed ID: 32850977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do inflammaging and coagul-aging play a role as conditions contributing to the co-occurrence of the severe hyper-inflammatory state and deadly coagulopathy during COVID-19 in older people?
    Xu K; Wei Y; Giunta S; Zhou M; Xia S
    Exp Gerontol; 2021 Aug; 151():111423. PubMed ID: 34048906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement Activation-Independent Attenuation of SARS-CoV-2 Infection by C1q and C4b-Binding Protein.
    Beirag N; Varghese PM; Neto MM; Al Aiyan A; Khan HA; Qablan M; Shamji MH; Sim RB; Temperton N; Kishore U
    Viruses; 2023 May; 15(6):. PubMed ID: 37376569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial cell dysfunction, coagulation, and angiogenesis in coronavirus disease 2019 (COVID-19).
    Norooznezhad AH; Mansouri K
    Microvasc Res; 2021 Sep; 137():104188. PubMed ID: 34022205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modelling and analysis of the complement system signalling pathways: roles of C3, C5a and pro-inflammatory cytokines in SARS-CoV-2 infection.
    Murad D; Zafar Paracha R; Saeed MT; Ahmad J; Mushtaq A; Humayun M
    PeerJ; 2023; 11():e15794. PubMed ID: 37744234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy.
    Eskandarian Boroujeni M; Sekrecka A; Antonczyk A; Hassani S; Sekrecki M; Nowicka H; Lopacinska N; Olya A; Kluzek K; Wesoly J; Bluyssen HAR
    Front Immunol; 2022; 13():888897. PubMed ID: 35663932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 Infection and C1-Esterase Inhibitor: Camouflage Pattern and New Perspective.
    Al-Kuraishy HM; Al-Gareeb AI; Jalal NA; Kabrah SM; Alexiou A; Batiha GE
    Curr Protein Pept Sci; 2022; 23(7):465-474. PubMed ID: 35959625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?
    Panigrahy D; Gilligan MM; Huang S; Gartung A; Cortés-Puch I; Sime PJ; Phipps RP; Serhan CN; Hammock BD
    Cancer Metastasis Rev; 2020 Jun; 39(2):337-340. PubMed ID: 32385712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Contribution of Complement Protein C1q in COVID-19 and HIV Infection Comorbid with Preeclampsia: A Review.
    Govender S; Naicker T
    Int Arch Allergy Immunol; 2022; 183(10):1114-1126. PubMed ID: 35661665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 Antibodies Mediate Complement and Cellular Driven Inflammation.
    Jarlhelt I; Nielsen SK; Jahn CXH; Hansen CB; Pérez-Alós L; Rosbjerg A; Bayarri-Olmos R; Skjoedt MO; Garred P
    Front Immunol; 2021; 12():767981. PubMed ID: 34804055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double edged-sword - The Complement System during SARS-CoV-2 infection.
    Santiesteban-Lores LE; Amamura TA; da Silva TF; Midon LM; Carneiro MC; Isaac L; Bavia L
    Life Sci; 2021 May; 272():119245. PubMed ID: 33609539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasculature-on-a-chip platform with innate immunity enables identification of angiopoietin-1 derived peptide as a therapeutic for SARS-CoV-2 induced inflammation.
    Lu RXZ; Lai BFL; Rafatian N; Gustafson D; Campbell SB; Banerjee A; Kozak R; Mossman K; Mubareka S; Howe KL; Fish JE; Radisic M
    Lab Chip; 2022 Mar; 22(6):1171-1186. PubMed ID: 35142777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.